News
Google has surged ahead in the enterprise AI race after perceived stumbles. VentureBeat details the Gemini models, TPU ...
Investors eye Vertex’s Q1 for Alyftrek and Journavx momentum amid Trikafta’s international headwinds. Vertex stock shows a bullish technical bias despite recent pullback and mixed short-term ...
Vertex Pharmaceuticals (NASDAQ: VRTX) had a fine Tuesday on the stock exchange. One of these two impactful publications was issued by Swiss bank UBS analyst Eliana Merle. The second of the pair ...
Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...
RICHARDSON THEATER. NEW AT SIX. A VIDEO POSTED ON X BY SOUTH CAROLINA REPRESENTATIVE NANCY MACE HAS NOW BEEN VIEWED MORE THAN 6 MILLION TIMES. SHE SAYS THE VIDEO WAS TAKEN WHILE SHE CLAIMS A MAN ...
Several Wisconsin-owned restaurants, including some local to Green Bay and De Pere, will have the rare opportunity to showcase their eats inside the NFL Draft campus. They will be featured in ...
Mervyn Tan, managing director, investment, at venture capital firm Vertex Holdings, will join the group to assume the roles, effective Jun 1. Singh, 61, will take on an advisory role from Jun 1, ST ...
Three people with type 1 diabetes who received Vertex Pharma’s islet cell therapy VX-880 have been able to come off insulin altogether within a year, raising the prospect of a life without ...
The exclusive, front row, access-all-areas programme for everything athletics. It's the place to watch and cheer your idols. To discover life behind the scenes and what it really takes to be the best, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results